Similar studies using HDAC inhibitors and erythropoietin have reported increases in frataxin protein expression in primary cells derived from patients with FRDA in vitro[9], [10], [13], [14], with studies showing increases in frataxin protein with and without corresponding increases in frataxin mRNA [9], [13]. This evidence concerns the gene FXN and Friedreich ataxia.